Dry Honey Product
This report aims to provide a comprehensive presentation of the global market for Dry Honey Produ ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Drug Repurposing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Oncology 1.2.3 CNS Diseases 1.2.4 Neurodegenerative Diseases 1.2.5 Others 1.3 Market by Application 1.3.1 Global Drug Repurposing Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Drug Repurposing Market Perspective (2018-2029) 2.2 Drug Repurposing Growth Trends by Region 2.2.1 Global Drug Repurposing Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Drug Repurposing Historic Market Size by Region (2018-2023) 2.2.3 Drug Repurposing Forecasted Market Size by Region (2024-2029) 2.3 Drug Repurposing Market Dynamics 2.3.1 Drug Repurposing Industry Trends 2.3.2 Drug Repurposing Market Drivers 2.3.3 Drug Repurposing Market Challenges 2.3.4 Drug Repurposing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Drug Repurposing Players by Revenue 3.1.1 Global Top Drug Repurposing Players by Revenue (2018-2023) 3.1.2 Global Drug Repurposing Revenue Market Share by Players (2018-2023) 3.2 Global Drug Repurposing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Drug Repurposing Revenue 3.4 Global Drug Repurposing Market Concentration Ratio 3.4.1 Global Drug Repurposing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Drug Repurposing Revenue in 2022 3.5 Drug Repurposing Key Players Head office and Area Served 3.6 Key Players Drug Repurposing Product Solution and Service 3.7 Date of Enter into Drug Repurposing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Drug Repurposing Breakdown Data by Type 4.1 Global Drug Repurposing Historic Market Size by Type (2018-2023) 4.2 Global Drug Repurposing Forecasted Market Size by Type (2024-2029) 5 Drug Repurposing Breakdown Data by Application 5.1 Global Drug Repurposing Historic Market Size by Application (2018-2023) 5.2 Global Drug Repurposing Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Drug Repurposing Market Size (2018-2029) 6.2 North America Drug Repurposing Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Drug Repurposing Market Size by Country (2018-2023) 6.4 North America Drug Repurposing Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Drug Repurposing Market Size (2018-2029) 7.2 Europe Drug Repurposing Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Drug Repurposing Market Size by Country (2018-2023) 7.4 Europe Drug Repurposing Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Drug Repurposing Market Size (2018-2029) 8.2 Asia-Pacific Drug Repurposing Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Drug Repurposing Market Size by Region (2018-2023) 8.4 Asia-Pacific Drug Repurposing Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Drug Repurposing Market Size (2018-2029) 9.2 Latin America Drug Repurposing Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Drug Repurposing Market Size by Country (2018-2023) 9.4 Latin America Drug Repurposing Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Drug Repurposing Market Size (2018-2029) 10.2 Middle East & Africa Drug Repurposing Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Drug Repurposing Market Size by Country (2018-2023) 10.4 Middle East & Africa Drug Repurposing Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Astellas Pharma 11.1.1 Astellas Pharma Company Detail 11.1.2 Astellas Pharma Business Overview 11.1.3 Astellas Pharma Drug Repurposing Introduction 11.1.4 Astellas Pharma Revenue in Drug Repurposing Business (2018-2023) 11.1.5 Astellas Pharma Recent Development 11.2 Biovista 11.2.1 Biovista Company Detail 11.2.2 Biovista Business Overview 11.2.3 Biovista Drug Repurposing Introduction 11.2.4 Biovista Revenue in Drug Repurposing Business (2018-2023) 11.2.5 Biovista Recent Development 11.3 Novartis 11.3.1 Novartis Company Detail 11.3.2 Novartis Business Overview 11.3.3 Novartis Drug Repurposing Introduction 11.3.4 Novartis Revenue in Drug Repurposing Business (2018-2023) 11.3.5 Novartis Recent Development 11.4 AbbVie 11.4.1 AbbVie Company Detail 11.4.2 AbbVie Business Overview 11.4.3 AbbVie Drug Repurposing Introduction 11.4.4 AbbVie Revenue in Drug Repurposing Business (2018-2023) 11.4.5 AbbVie Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Detail 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Drug Repurposing Introduction 11.5.4 Pfizer Revenue in Drug Repurposing Business (2018-2023) 11.5.5 Pfizer Recent Development 11.6 Allergan 11.6.1 Allergan Company Detail 11.6.2 Allergan Business Overview 11.6.3 Allergan Drug Repurposing Introduction 11.6.4 Allergan Revenue in Drug Repurposing Business (2018-2023) 11.6.5 Allergan Recent Development 11.7 NuMedii 11.7.1 NuMedii Company Detail 11.7.2 NuMedii Business Overview 11.7.3 NuMedii Drug Repurposing Introduction 11.7.4 NuMedii Revenue in Drug Repurposing Business (2018-2023) 11.7.5 NuMedii Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global Drug Repurposing Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Oncology Table 3. Key Players of CNS Diseases Table 4. Key Players of Neurodegenerative Diseases Table 5. Key Players of Others Table 6. Global Drug Repurposing Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Drug Repurposing Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 8. Global Drug Repurposing Market Size by Region (2018-2023) & (US$ Million) Table 9. Global Drug Repurposing Market Share by Region (2018-2023) Table 10. Global Drug Repurposing Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 11. Global Drug Repurposing Market Share by Region (2024-2029) Table 12. Drug Repurposing Market Trends Table 13. Drug Repurposing Market Drivers Table 14. Drug Repurposing Market Challenges Table 15. Drug Repurposing Market Restraints Table 16. Global Drug Repurposing Revenue by Players (2018-2023) & (US$ Million) Table 17. Global Drug Repurposing Market Share by Players (2018-2023) Table 18. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2022) Table 19. Ranking of Global Top Drug Repurposing Companies by Revenue (US$ Million) in 2022 Table 20. Global 5 Largest Players Market Share by Drug Repurposing Revenue (CR5 and HHI) & (2018-2023) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Drug Repurposing Product Solution and Service Table 23. Date of Enter into Drug Repurposing Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Drug Repurposing Market Size by Type (2018-2023) & (US$ Million) Table 26. Global Drug Repurposing Revenue Market Share by Type (2018-2023) Table 27. Global Drug Repurposing Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 28. Global Drug Repurposing Revenue Market Share by Type (2024-2029) Table 29. Global Drug Repurposing Market Size by Application (2018-2023) & (US$ Million) Table 30. Global Drug Repurposing Revenue Market Share by Application (2018-2023) Table 31. Global Drug Repurposing Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 32. Global Drug Repurposing Revenue Market Share by Application (2024-2029) Table 33. North America Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 34. North America Drug Repurposing Market Size by Country (2018-2023) & (US$ Million) Table 35. North America Drug Repurposing Market Size by Country (2024-2029) & (US$ Million) Table 36. Europe Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 37. Europe Drug Repurposing Market Size by Country (2018-2023) & (US$ Million) Table 38. Europe Drug Repurposing Market Size by Country (2024-2029) & (US$ Million) Table 39. Asia-Pacific Drug Repurposing Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 40. Asia-Pacific Drug Repurposing Market Size by Region (2018-2023) & (US$ Million) Table 41. Asia-Pacific Drug Repurposing Market Size by Region (2024-2029) & (US$ Million) Table 42. Latin America Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 43. Latin America Drug Repurposing Market Size by Country (2018-2023) & (US$ Million) Table 44. Latin America Drug Repurposing Market Size by Country (2024-2029) & (US$ Million) Table 45. Middle East & Africa Drug Repurposing Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 46. Middle East & Africa Drug Repurposing Market Size by Country (2018-2023) & (US$ Million) Table 47. Middle East & Africa Drug Repurposing Market Size by Country (2024-2029) & (US$ Million) Table 48. Astellas Pharma Company Detail Table 49. Astellas Pharma Business Overview Table 50. Astellas Pharma Drug Repurposing Product Table 51. Astellas Pharma Revenue in Drug Repurposing Business (2018-2023) & (US$ Million) Table 52. Astellas Pharma Recent Development Table 53. Biovista Company Detail Table 54. Biovista Business Overview Table 55. Biovista Drug Repurposing Product Table 56. Biovista Revenue in Drug Repurposing Business (2018-2023) & (US$ Million) Table 57. Biovista Recent Development Table 58. Novartis Company Detail Table 59. Novartis Business Overview Table 60. Novartis Drug Repurposing Product Table 61. Novartis Revenue in Drug Repurposing Business (2018-2023) & (US$ Million) Table 62. Novartis Recent Development Table 63. AbbVie Company Detail Table 64. AbbVie Business Overview Table 65. AbbVie Drug Repurposing Product Table 66. AbbVie Revenue in Drug Repurposing Business (2018-2023) & (US$ Million) Table 67. AbbVie Recent Development Table 68. Pfizer Company Detail Table 69. Pfizer Business Overview Table 70. Pfizer Drug Repurposing Product Table 71. Pfizer Revenue in Drug Repurposing Business (2018-2023) & (US$ Million) Table 72. Pfizer Recent Development Table 73. Allergan Company Detail Table 74. Allergan Business Overview Table 75. Allergan Drug Repurposing Product Table 76. Allergan Revenue in Drug Repurposing Business (2018-2023) & (US$ Million) Table 77. Allergan Recent Development Table 78. NuMedii Company Detail Table 79. NuMedii Business Overview Table 80. NuMedii Drug Repurposing Product Table 81. NuMedii Revenue in Drug Repurposing Business (2018-2023) & (US$ Million) Table 82. NuMedii Recent Development Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Global Drug Repurposing Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Drug Repurposing Market Share by Type: 2022 VS 2029 Figure 3. Oncology Features Figure 4. CNS Diseases Features Figure 5. Neurodegenerative Diseases Features Figure 6. Others Features Figure 7. Global Drug Repurposing Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 8. Global Drug Repurposing Market Share by Application: 2022 VS 2029 Figure 9. Hospitals Case Studies Figure 10. Ambulatory Surgical Centers Case Studies Figure 11. Others Case Studies Figure 12. Drug Repurposing Report Years Considered Figure 13. Global Drug Repurposing Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Drug Repurposing Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Drug Repurposing Market Share by Region: 2022 VS 2029 Figure 16. Global Drug Repurposing Market Share by Players in 2022 Figure 17. Global Top Drug Repurposing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repurposing as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Drug Repurposing Revenue in 2022 Figure 19. North America Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Drug Repurposing Market Share by Country (2018-2029) Figure 21. United States Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Drug Repurposing Market Share by Country (2018-2029) Figure 25. Germany Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Drug Repurposing Market Share by Region (2018-2029) Figure 33. China Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Drug Repurposing Market Share by Country (2018-2029) Figure 41. Mexico Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Drug Repurposing Market Share by Country (2018-2029) Figure 45. Turkey Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Drug Repurposing Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. Astellas Pharma Revenue Growth Rate in Drug Repurposing Business (2018-2023) Figure 48. Biovista Revenue Growth Rate in Drug Repurposing Business (2018-2023) Figure 49. Novartis Revenue Growth Rate in Drug Repurposing Business (2018-2023) Figure 50. AbbVie Revenue Growth Rate in Drug Repurposing Business (2018-2023) Figure 51. Pfizer Revenue Growth Rate in Drug Repurposing Business (2018-2023) Figure 52. Allergan Revenue Growth Rate in Drug Repurposing Business (2018-2023) Figure 53. NuMedii Revenue Growth Rate in Drug Repurposing Business (2018-2023) Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed
Astellas Pharma Biovista Novartis AbbVie Pfizer Allergan NuMedii
This report aims to provide a comprehensive presentation of the global market for Dry Honey Produ ... Read More
This report aims to provide a comprehensive presentation of the global market for Drying & Storag ... Read More
This report aims to provide a comprehensive presentation of the global market for Drywall & Build ... Read More
This report aims to provide a comprehensive presentation of the global market for Dual Access Cat ... Read More